...
首页> 外文期刊>癌と化学療法 >Intra-arterial chemotherapy for head and neck cancer
【24h】

Intra-arterial chemotherapy for head and neck cancer

机译:头部和颈部癌症的动脉内化疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There are historically speaking, three methods of intra-arterial infusion for head and neck cancer. Recently, daily concurrent chemoradiotherapy using new superselective intra-arterial infusion via superficial temporal arterial artery is noted. A catheter with a curved tip is inserted superselectively to the feeding artery of the tumor via the superficial temporal artery. Long-term catheterization is possible in this method. Thirty-five patients with stage III or IV oral cancer were treated. Radiotherapy (total dose:40 Gy/4 weeks) and superselective intra-arterial infusion chemotherapy using DOC (total dose: 60 mg/m2, 15 mg/m2/week) and CDDP total dose: 100 mg/m2, 5 mg/m2/day) were concurrently performed daily, followed by surgery. In 31 patients, intra-arterial infusion was successful(successful rate: 88.6%), and no major complication was observed. The clinical effects were CR in 25 patients(80.6%), and pathological effects of resected tumor after surgery were pathological CR in 28 (90.3%). This method promises to be new strategy of choice for the treatment of head and neck cancer.
机译:在历史上讲,三种动脉内输液方法,用于头部和颈部癌症。最近,注意到通过浅表颞型动脉动脉使用新的超出动脉内输注的每日同时进行化学疗法。具有弯曲尖端的导管通过浅表颞型动脉覆盖肿瘤的饲喂动脉。这种方法可以实现长期导管。治疗三十五名患有III期或IV型口腔癌的患者。放射疗法(总剂量:40 GY / 4周)和使用DOC的动脉内输注化疗(总剂量:60mg / m 2,15mg / m 2 /周)和CDDP总剂量:100mg / m 2,5mg / m 2 /天)每天同时进行,然后进行手术进行。在31例患者中,动脉内输注成功(成功率:88.6%),并且没有观察到主要并发症。临床疗效在25名患者(80.6%)中,手术后切除肿瘤的病理学效应是病态Cr 28(90.3%)。这种方法有望成为头部和颈部癌症治疗的新策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号